Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study
Journal
Indian heart journal
Journal Volume
75
Journal Issue
2
Pages
115-121
Date Issued
2023-03-01
Author(s)
Singh, Balbir
Hsieh, Yu-Cheng
Lin, Kuo-Hung
Joung, Boyoung
Rodriguez, Diego A
Chasnoits, Alexandr R
Huang, Dejia
Zhang, Shu
O'Brien, Janet E
Lexcen, Daniel R
Cerkvenik, Jeffrey
Van Dorn, Brian
Ching, Chi-Keong
Abstract
Despite the burden of sudden cardiac arrest (SCA) worldwide, implantable cardioverter-defibrillators (ICDs) are underutilized, particularly in Asia, Latin America, Eastern Europe, the Middle East, and Africa. The Improve SCA trial demonstrated that primary prevention (PP) patients in these regions benefit from an ICD or a cardiac resynchronization therapy defibrillator (CRT-D). We aimed to compare the rate of device therapy and mortality among ischemic and non-ischemic cardiomyopathy (ICM and NICM) PP patients who met guideline indications for ICD therapy and had an ICD/CRT-D implanted.
Subjects
Heart failure; Implantable cardioverter defibrillators; Sudden cardiac arrest; Sudden cardiac death; Ventricular arrhythmias
SDGs
Type
journal article